Insider · CIK 0001733272

Yocca Frank

Reports to the SEC for 1 company · NEW HAVEN, CT

sec.gov

Transactions

Companies

Filings

CIK

0001733272

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-15	BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+35 sh	—	—	26,210
2026-06-15	BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−35 sh	—	—	212
2026-05-20	BTAIBioXcel Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−6,845 sh	$1.08	−$7,426.825	26,175
2026-05-04	BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+17.5K sh	—	—	33,020
2026-05-04	BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−17.5K sh	—	—	52,500
2026-05-01	BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+9,000 sh	—	—	15,520
2026-05-01	BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−9,000 sh	—	—	0
2026-03-15	BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+35 sh	—	—	6,520
2026-03-15	BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−35 sh	—	—	247
2026-03-14	BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+33 sh	—	—	6,485
2026-03-14	BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−33 sh	—	—	97
2026-01-01	BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsA Award	Chief Scientific Officer	AAward	+70K sh	—	—	70,282
2025-12-15	BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+35 sh	—	—	6,452
2025-12-15	BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−35 sh	—	—	282
2025-12-14	BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+33 sh	—	—	6,417
2025-12-14	BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−33 sh	—	—	130
2025-09-15	BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+35 sh	—	—	6,384
2025-09-15	BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−35 sh	—	—	317
2025-09-14	BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+33 sh	—	—	6,349
2025-09-14	BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−33 sh	—	—	163
2025-08-01	BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsA Award	Chief Scientific Officer	AAward	+9,000 sh	—	—	9,000
2025-07-22	BTAIBioXcel Therapeutics, Inc.A Award	Chief Scientific Officer	AAward	+4,375 sh	—	—	6,316
2025-06-15	BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+35 sh	—	—	1,941
2025-06-15	BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−35 sh	—	—	352
2025-06-14	BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+33 sh	—	—	1,906
2025-06-14	BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−33 sh	—	—	196
2025-03-15	BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+34 sh	—	—	1,873
2025-03-15	BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−34 sh	—	—	387
2025-03-14	BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+31 sh	—	—	1,839
2025-03-14	BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−31 sh	—	—	229
2025-01-07	BTAIBioXcel Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+270K sh	—	—	270,000
2024-12-16	BTAIBioXcel Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−205 sh	$0.36	−$72.796	29,156
2024-12-16	BTAIBioXcel Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−225 sh	$0.35	−$79.02	28,931
2024-12-15	BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+562 sh	—	—	29,361
2024-12-15	BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−562 sh	—	—	5,064
2024-12-14	BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+521 sh	—	—	28,799
2024-12-14	BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−521 sh	—	—	2,606
2024-10-03	BTAIBioXcel Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−7,175 sh	$0.55	−$3,946.25	28,278
2024-09-17	BTAIBioXcel Therapeutics, Inc.A Award	Chief Scientific Officer	AAward	+21.3K sh	—	—	35,453
2024-09-16	BTAIBioXcel Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−355 sh	$0.69	−$244.702	14,203
2024-09-15	BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+563 sh	—	—	14,558
2024-09-15	BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−563 sh	—	—	5,625
2024-09-14	BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+521 sh	—	—	13,995
2024-09-14	BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−521 sh	—	—	3,127
2024-07-22	BTAIBioXcel Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+1,875 sh	—	—	1,875
2024-06-17	BTAIBioXcel Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−372 sh	$1.28	−$476.16	13,474
2024-06-15	BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+562 sh	—	—	13,846
2024-06-15	BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−562 sh	—	—	6,188
2024-06-14	BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+521 sh	—	—	13,284
2024-06-14	BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−521 sh	—	—	3,648

Recent filings

Accepted (ET)
Jun 174
Yocca Frank0001104659-26-075300
SEC(opens sec.gov)
May 224
Yocca Frank0001104659-26-065841
SEC(opens sec.gov)
May 74
Yocca Frank0001104659-26-057365
SEC(opens sec.gov)
Mar 164
Yocca Frank0001104659-26-028718
SEC(opens sec.gov)
Jan 54
Yocca Frank0001104659-26-000838
SEC(opens sec.gov)
Dec 154
Yocca Frank0001104659-25-121300
SEC(opens sec.gov)
Sep 164
Yocca Frank0001104659-25-090514
SEC(opens sec.gov)

Companies

BioXcel Therapeutics, Inc.Chief Scientific OfficerBTAI

Address

C/O BIOXCEL THERAPEUTICS, INC. 555 LONG WHARF DRIVE, 12TH FLOOR

NEW HAVEN, CT, 06511